Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature

被引：27

作者：

Capaccione, Kathleen M. ^{[1
]}

Leb, Jay S. ^{[1
]}

D'souza, Belinda ^{[1
]}

Utukuri, Pallavi ^{[1
]}

Salvatore, Mary M. ^{[1
]}

机构：

[1] Columbia Univ, Irving Med Ctr, Dept Radiol, 622 W 168th St, New York, NY 10032 USA

来源：

CLINICAL IMAGING | 2021年 / 72卷

关键词：

COVID-19; Acute coronary syndrome; Cardiac MRI; Thrombosis;

D O I：

10.1016/j.clinimag.2020.11.030

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Background: Thrombotic complications of COVID-19 infection have become increasingly apparent as the disease has infected a growing number of individuals. Although less common than upper respiratory symptoms, thrombotic complications are not infrequent and may result in severe and long-term sequelae. Common thrombotic complications include pulmonary embolism, cerebral infarction, or venous thromboembolism; less commonly seen are acute myocardial injury, renal artery thrombosis, and mesenteric ischemia. Several case reports and case series have described acute myocardial injury in patients with COVID-19 characterized by elevations in serum biomarkers. Case report: Here, we report the first case to our knowledge of a patient with acute coronary syndrome confirmed on catheter angiography and cardiac MRI. This patient was found to additionally have a left ventricular thrombus and ultimately suffered an acute cerebral infarction. Recognition of thrombotic complications in the setting of COVID-19 infection is essential for initiating appropriate therapy. Conclusions: In acute myocardial injury, given the different treatment strategies for myocarditis versus acute myocardial infarction secondary to coronary artery thrombus, imaging can play a key role in clinical decision making for patients.

引用

页码：178 / 182

页数：5

共 37 条

[1]

Chen N., Zhou M., Dong X., Et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 10223, pp. 507-513, (2020)

[2]

Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res, 191, pp. 145-147, (2020)

[3]

Helms J., Tacquard C., Severac F., Et al., High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study, Intensive Care Med, 46, 6, pp. 1089-1098, (2020)

[4]

Dolhnikoff M., Duarte-Neto A.N., de Almeida Monteiro R.A., Et al., Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19, J Thromb Haemost, 18, 6, pp. 1517-1519, (2020)

[5]

Reddy S.T., Garg T., Shah C., Et al., Cerebrovascular disease in patients with COVID-19: a review of the literature and case series, Case Rep Neurol, 12, 2, pp. 199-209, (2020)

[6]

Kaminetzky M., Moore W., Fansiwala K., Et al., Pulmonary embolism on CTPA in COVID-19 patients, Radiol Cardiothorac Imaging, 2, 4, (2020)

[7]

Porfidia A., Valeriani E., Pola R., Porreca E., Rutjes A.W.S., Di Nisio M., Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis, Thromb Res, 196, pp. 67-74, (2020)

[8]

Su H., Yang M., Wan C., Et al., Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int, 98, 1, pp. 219-227, (2020)

[9]

Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X., COVID-19 and the cardiovascular system, Nat Rev Cardiol, 17, 5, pp. 259-260, (2020)

[10]

Parry A.H., Wani A.H., Yaseen M., Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway, Acad Radiol, 27, 8, (2020)

← 1 2 3 4 →